PASGAfter a double bottom a small triangle has formed, the brekkout of this triangle could project towards 2.80, otherwise a return to the lows
−1.86USD
−102.06 MUSD
41.24 M
About Passage Bio, Inc.
Sector
Industry
CEO
William Chou
Website
Headquarters
Philadelphia
Employees (FY)
58
Founded
2017
FIGI
BBG00NBK4XF9
Passage Bio, Inc. operates as a genetic medicines company. It focuses on developing transformative therapies for rare, monogenic central nervous system disorders with limited or no approved treatment options. The company assembles a portfolio of genetic medicine products, which includes PBGM01 for the treatment of GM1, PBFT02 for the treatment of FTD and PBKR03 for the treatment of Krabbe disease. Passage Bio was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
PASG longLet me know what you think, PASG has hit one of their lowest point twice now. Strong feelings that it is going to go up.
PASG longJust an idea, not the financial advice. Do your own research.
It has ~2-3weeks of consolidation within the box with the support area at 18-19.
It gapped down because of the offering. And the offering in biostock is usually a temporary weakness and the money from the offering goes not just for corp
PASG what will do!?After public shere ofering this company pull back for 2 days! But she found a resistence at 20 dolars! If she not break resistence, i think that she can do a pull back to 24-25 dolars in 2 days!
Good entry point 20/21 dolars target 24 dolars! Stop lose 20 dolars
This its just my opinion and not a
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PASG is 1.14 USD — it has decreased by 0.87% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Passage Bio, Inc. stocks are traded under the ticker PASG.
Passage Bio, Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
PASG stock is 6.01% volatile and has beta coefficient of 1.89. Check out the list of the most volatile stocks — is Passage Bio, Inc. there?
One year price forecast for Passage Bio, Inc. has a max estimate of 14.00 USD and a min estimate of 3.00 USD.
PASG earnings for the last quarter are −0.49 USD per share, whereas the estimation was −0.46 USD resulting in a −7.30% surprise. The estimated earnings for the next quarter are −0.39 USD per share. See more details about Passage Bio, Inc. earnings.
Yes, you can track Passage Bio, Inc. financials in yearly and quarterly reports right on TradingView.
PASG stock has fallen by 16.18% compared to the previous week, the month change is a 16.79% fall, over the last year Passage Bio, Inc. has showed a 11.76% increase.
PASG net income for the last quarter is −16.76 M USD, while the quarter before that showed −27.11 M USD of net income which accounts for 38.19% change. Track more Passage Bio, Inc. financial stats to get the full picture.
Today Passage Bio, Inc. has the market capitalization of 70.85 M, it has increased by 3.85% over the last week.
No, PASG doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PASG shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Passage Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 58.00 employees. See our rating of the largest employees — is Passage Bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Passage Bio, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Passage Bio, Inc. stock shows the sell signal. See more of Passage Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Passage Bio, Inc. future price: according to them, PASG price has a max estimate of 14.00 USD and a min estimate of 3.00 USD. Read a more detailed Passage Bio, Inc. forecast: see what analysts think of Passage Bio, Inc. and suggest that you do with its stocks.